The tariff classification of Peritoneal Dialysis (PD) solutions of Extraneal® (icodextrin) and Dianeal® (dextrose), in dosage form, from Mexico
No revocation or modification of this ruling appears in the Customs Bulletin issues read here (Nov 6, 2024 through Nov 18, 2026), where CBP publishes most such actions. That is not confirmation that the ruling is still in effect. Confirm its status with CBP before relying on it (ruling on CBP CROSS).
Ruling text
In your letter dated April 11, 2025, filed on behalf of Vantive US Healthcare LLC, you requested a tariff classification ruling. We note that the request did not seek a determination as to country of origin, or as to the applicability of preferential treatment under the U.S.-Mexico-Canada Agreement; as such, this ruling does not address those issues.
The Peritoneal Dialysis (PD) solutions imported in ultrabags are used to remove excess fluid, correct electrolyte problems, and remove toxins in those with kidney failure. Extraneal (icodextrin) is indicated for the management of kidney failure in patients requiring long-term kidney replacement therapy. Dianeal (dextrose) is indicated for the management of acute or chronic renal failure.
The applicable subheading for the Peritoneal Dialysis (PD) solutions of Extraneal® (icodextrin) and Dianeal® (dextrose) in dosage form will be 3004.90.9270, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments…consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses…or in forms or packings for retail sale: Other: Other: Other: Preparations primarily affecting the electrolytic, caloric or water balance: Other.” The HTSUS column 1 rate of duty will be free.
In your submission you requested consideration of a secondary classification under 9817.00.96, HTSUS, which applies to articles and parts and accessories of articles specifically designed or adapted for the use or benefit of the permanently or chronically physically or mentally handicapped.
Subheading 9817.00.96, HTSUS, covers: “Articles specially designed or adapted for the use or benefit of the blind or other physically or mentally handicapped persons; parts and accessories (except parts and accessories of braces and artificial limb prosthetics) that are specially designed or adapted for use in the foregoing articles . . .
Other.” The term “blind or other physically or mentally handicapped persons” includes “any person suffering from a permanent or chronic physical or mental impairment which substantially limits one or more major life activities, such as caring for one’s self, performing manual tasks, walking, seeing, hearing, speaking, breathing, learning, or working.” U.S. Note 4(a), Subchapter XVII, Chapter 98, HTSUS.
Subheading 9817.00.96, HTSUS, excludes “(i) articles for acute or transient disability; (ii) spectacles, dentures, and cosmetic articles for individuals not substantially disabled; (iii) therapeutic and diagnostic articles; or, (iv) medicine or drugs.” U.S. Note 4(b), Subchapter XVII, Chapter 98, HTSUS.
Thus, eligibility within subheading 9817.00.96, HTSUS, depends on whether the article is “specially designed or adapted for the use or benefit of the blind or physically and mentally handicapped persons,” and whether it falls within an y of the enumerated exclusions under U.S. Note 4(b), Subchapter XVII, Chapter 98, HTSUS.
The text above is an excerpt. The official ruling, with its letterhead, signature and any attachments, is on CBP CROSS (N347734).